China Pharma Holdings (CPHI) EPS (Basic) Growth (1y) (2012 - 2026)
China Pharma Holdings (CPHI) EPS (Basic) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | China Pharma Holdings | 41.74 Mn | 41.43 Mn | 83,566.00 | 77.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.46% |
| Dec 31, 2025 | 59.38% |
| Sep 30, 2025 | 73.97% |
| Jun 30, 2025 | 81.84% |
| Mar 31, 2025 | 66.91% |
| Dec 31, 2024 | 80.75% |
| Sep 30, 2024 | 78.04% |
| Jun 30, 2024 | 70.17% |
| Mar 31, 2024 | 75.29% |
| Dec 31, 2023 | 69.71% |
| Sep 30, 2023 | 62.79% |
| Jun 30, 2023 | 67.36% |
| Mar 31, 2023 | 72.89% |
| Dec 31, 2022 | -13.11% |
| Sep 30, 2022 | 12.02% |
| Jun 30, 2022 | -1.25% |
| Mar 31, 2022 | -29.10% |
| Dec 31, 2021 | 23.29% |
| Sep 30, 2021 | 22.45% |
| Jun 30, 2021 | -6,141.30% |